Acrobiosystems Co

Acrobiosystems Co P/TBV

The Price to Tangible Book Value (P/TBV) of Acrobiosystems Co (301080.SZ) as of Nov 21, 2026 is 3.70. In the previous year, Price to Tangible Book Value (P/TBV) was 3.82 — a change of -2.98% (lower).

P/TBV

3.70

YoY

-2.98%

Last updated:

Price to Tangible Book Value (P/TBV) of Acrobiosystems Co is 2025 3.70 . Price to Tangible Book Value (P/TBV) of Acrobiosystems Co was 2024 3.82 . It decreases by -2.98% lower compared to the previous year.

The Acrobiosystems Co P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
136.01 CNY
Jan 1, 2019
102.05 CNY
Jan 1, 2020
49.31 CNY
Jan 1, 2021
4.00 CNY
Jan 1, 2022
3.86 CNY
Jan 1, 2023
3.86 CNY
Jan 1, 2024
3.82 CNY
Jan 1, 2025
3.70 CNY
The Acrobiosystems Co P/TBV history
YEARP/TBVYoY
3.70-2.98%
3.82-1.00%
3.86-0.05%
3.86-3.42%
4.00-91.90%
49.31-51.68%
102.05-24.97%
136.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acrobiosystems Co Stock analysis

What does Acrobiosystems Co do? Acrobiosystems Co Ltd develops biomedicine and bio-protein technology, focusing on recombinant proteins, detection services, kits, antibodies, fillers, and culture media. The company serves R&D and production sectors for drug discovery, screening, diagnostic reagents, and clinical trials across tumor, autoimmune, cardiovascular, and infectious disease areas. Its products support early drug development stages and process control in pharmaceutical manufacturing. The firm's main customers are pharmaceutical companies and research institutions requiring advanced biotech solutions for disease treatment development. The company generates revenue through the sale of recombinant proteins, detection services, and related products like kits and antibodies. These offerings are tailored for pharmaceutical firms engaged in drug development and diagnostic reagent optimization. Acrobiosystems' product portfolio targets the biopharmaceutical industry, specifically addressing needs in tumor, autoimmune, cardiovascular, and infectious disease research. The firm's services are utilized in preclinical and clinical trial phases to enhance drug development efficiency. Acrobiosystems' main products include recombinant proteins, kits, antibodies, fillers, and culture media, which are sold to pharmaceutical companies and research organizations. These entities use the products for early-stage drug discovery, verification, and optimization processes. The company's detection services support diagnostic reagent development and drug screening, directly contributing to the pharmaceutical R&D pipeline. The firm's focus on CMC (process control) for drug production ensures its offerings align with critical manufacturing stages in biopharmaceutical development. Acrobiosystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acrobiosystems Co stock

Price to Tangible Book Value (P/TBV) of Acrobiosystems Co is 3.70 in 2025.

Price to Tangible Book Value (P/TBV) of Acrobiosystems Co changed from 3.82 to 3.70, representing a -2.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Acrobiosystems Co since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Acrobiosystems Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Acrobiosystems Co

All Key Metrics — Acrobiosystems Co